Clinical Trial Update: Reduced-Intensity Conditioning (RIC) and Myeloablative Conditioning (MAC) for HSCT in AML/MDS [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update comparing reduced-intensity conditioning and myeloablative conditioning for hematopoietic stem cell transplantation in acute myelo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Snippet

Sponsor: Randy Windreich | Conditions: Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) | Phase 2 | Status: COMPLETED | Results posted: 2024-07-16